AOC 1044

· Avidity Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AOC 1044, covering 2025-05-14 to 2025-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping [Phase 1, Phase 2]

See pricing